Smithfield Is Still Proving Itself to Investors

Smithfield’s IPO stumbled, but its pivot to packaged meats is winning over Wall Street – slowly. Despite strong returns, investors remain wary of ownership optics, GLP-1 headwinds, and valuation lag.

FI Fast Break audio news: Aug. 5, 2025

The latest FI Fast Break news podcast touches on one CEO’s alarming prediction regarding the banana supply, plus more trending industry news.

Appetite for Reduction: GLP-1 Drugs Fuel Grocery Decrease

The market for GLP-1 drugs is expected to reach $100 billion by 2030. Manufacturers and brands who want a piece of the low-sugar pie, so to speak, will have to offer the same.

Analysis: Ozempic Likely to Impact Snack Manufacturers’ Bottom Line

The recent rise of Ozempic and other weight-loss drugs started with blowout results that drove shares of their manufacturers higher, then wound up cascading across seemingly disparate sectors. In 2023, Novo Nordisk, the manufacturer of …

Ozempic & Other Drugs: Explaining the Weight-Loss Medication Craze

Several medications approved to treat diabetes are being used as “miracle” weight-loss drugs, and the category continues to grow.